TRARO (Traumeel® S in Rotator Cuff Syndrome)-Study
Status:
Completed
Trial end date:
2014-06-01
Target enrollment:
Participant gender:
Summary
To evaluate functional, clinical, and subjective parameters in patients with rotator cuff
syndrome and bursitis treated with Traumeel® S injections versus corticosteroid injections
and versus placebo. 160 patients are planned to be randomised (i.e., 64 patients per active
treatment group and 32 patients in the placebo group) in 9 investigator sites in Germany,
Belgium and Spain.
Finally 176 patients have been randomized (73 Traumeel, 67 Fortecortin and 36 Placebo) and
175 of them received at least one dosage of treatment